Abstract: |
Sinonasal carcinomas (SNC) comprise a diverse morphologic and genetic spectrum of tumors. NUT carcinoma, SMARCB1-deficient SNC, and sinonasal undifferentiated carcinoma (SNUC) are rare and biologically aggressive, and, although often histologically remarkably similar, these three entities are genetically very distinct. An accurate molecular diagnosis portends a diagnostic value and can identify patients eligible for clinical trials with targeted therapies. Immunohistochemistry (IHC) for NUT and SMARCB1 (INI1) are useful surrogate diagnostic markers in all NUT and SMARCB1-deficient SNC, respectively. IDH2 R172S/T (11C8B1) IHC is a useful adjunct diagnostic marker in at least 70% SNUC. © Springer Nature Switzerland AG 2020. |